SEGLCELLESYGDOM
Forebygge kritisk situation
Dansk
Forebygge kritisk situation
/assets/ct/a63ae92c98/images/syn_placeholder_sqr.png

Seglcellesygdom

Forebygge kritisk situation

Farmakologisk induktion af føtalt hæmoglobin

Safety of hydroxyurea in pregnancy: a systematic review of the literature. (åbner nyt vindue)

Al Sulaimani R, Zitoun N, Alothman H, Hutson JR, Garcia-Bournissen F

Kilde‎: J Obstet Gynaecol Can. 2025 Jul;47(7):102924.

Indekseret‎: PubMed 40381805

DOI‎: 10.1016/j.jogc.2025.102924

https://pubmed.ncbi.nlm.nih.gov/40381805/ (åbner nyt vindue)

Outcomes of pregnancies in sickle cell patients treated with hydroxyurea : findings from the escort-HU cohort studies. (åbner nyt vindue)

Anoosha Habibi, Maryse Etienne-Julan, Maria Dimopoulou, Gylna Loko, Pagona Flevari, Narcisse Elenga, Sylvain LE Jeune, Estelle Jean, Laura Thomas-Bourgneuf, Jean-Benoit Arlet, Stephanie NGO, Emmanuelle Bernit, Corinne Charneau, Justine Dautremer, Laure Joseph, Giovanna Cannas, Pablo Bartolucci

Kilde‎: Blood 2025;146(Suppl 1):2-3.

Indekseret‎: DOI

DOI‎: 10.1182/blood-2025-2

https://ashpublications.org/blood/article/146/Supplement%201/2/553643/Outcomes-of-pregnancies-in-sickle-cell-patients (åbner nyt vindue)

Systematic review: hydroxyurea for the treatment of adults with sickle cell disease. (åbner nyt vindue)

Lanzkron S, Strouse JJ, Wilson R, Beach MC, Haywood C, Park H, Witkop C, Bass EB, Segal JB.

Kilde‎: Ann Intern Med 2008;148(12):939-55.

Indekseret‎: PubMed 18458272

https://www.ncbi.nlm.nih.gov/pubmed/18458272 (åbner nyt vindue)

Hydroxyurea for the treatment of sickle cell anemia. (åbner nyt vindue)

Platt OS.

Kilde‎: N Engl J Med 2008;358(13):1362-9.

Indekseret‎: PubMed 18367739

DOI‎: 10.1056/NEJMct0708272

https://www.ncbi.nlm.nih.gov/pubmed/18367739 (åbner nyt vindue)

Clinical effectiveness of decitabine in severe sickle cell disease. (åbner nyt vindue)

Saunthararajah Y, Molokie R, Saraf S, Sidhwani S, Gowhari M, Vara S, Lavelle D, DeSimone J.

Kilde‎: Br J Haematol 2008;141(1):126-9.

Indekseret‎: PubMed 18324975

DOI‎: 10.1111/j.1365-2141.2008.07027.x

https://www.ncbi.nlm.nih.gov/pubmed/18324975 (åbner nyt vindue)

The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS). (åbner nyt vindue)

Voskaridou E, Christoulas D, Bilalis A, Plata E, Varvagiannis K, Stamatopoulos G, Sinopoulou K, Balassopoulou A, Loukopoulos D, Terpos E.

Kilde‎: Blood 2010;115(12):2354-63.

Indekseret‎: PubMed 19903897

DOI‎: 10.1182/blood-2009-05-221333

https://www.ncbi.nlm.nih.gov/pubmed/19903897 (åbner nyt vindue)

Forebygge infektioner og andre komplikationer

Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease. (åbner nyt vindue)

Hirst C, Owusu-Ofori S.

Kilde‎: Cochrane Database Syst Rev 2012;(9):CD003427.

Indekseret‎: PubMed 22972063

DOI‎: 10.1002/14651858.CD003427.pub2

https://www.ncbi.nlm.nih.gov/pubmed/22972063 (åbner nyt vindue)

Sickle cell disease. (åbner nyt vindue)

Meremikwu MM, Okomo U.

Kilde‎: BMJ Clin Evid 2011;02:2402.

Indekseret‎: PubMed 21718552

https://www.ncbi.nlm.nih.gov/pubmed/21718552 (åbner nyt vindue)

A phase 3 trial of l-glutamine in sickle cell disease. (åbner nyt vindue)

Niihara Y, Miller ST, Kanter J, Lanzkron S, Smith WR, Hsu LL, Gordeuk VR, Viswanathan K, Sarnaik S, Osunkwo I, Guillaume E, Sadanandan S, Sieger L, Lasky JL, Panosyan EH, Blake OA, New TN, Bellevue R, Tran LT, Razon RL, Stark CW, Neumayr LD, Vichinsky EP

Kilde‎: N Engl J Med 2018;379(3):226-35.

Indekseret‎: PubMed 30021096

DOI‎: 10.1056/NEJMoa1715971

https://www.ncbi.nlm.nih.gov/pubmed/30021096 (åbner nyt vindue)

Malaria chemoprophylaxis in sickle cell disease. (åbner nyt vindue)

Oniyangi O, Omari AA.

Kilde‎: Cochrane Database Syst Rev 2006;(4):CD003489.

Indekseret‎: PubMed 17054173

DOI‎: 10.1002/14651858.CD003489.pub2

https://www.ncbi.nlm.nih.gov/pubmed/17054173 (åbner nyt vindue)